Fig. 2From: Intellectual property and access to medicines: mapping public attitudes toward pharmaceuticals during the United States-Mexico-Canada Agreement (USMCA) negotiation processGovernment stakeholders involved in US trade negotiations. Trade committees and advisory groups are highlighted in greyBack to article page